SOUTH
SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11,
2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the
"Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company
focused on developing novel therapies for treatment of prostate
cancer, today announced that the Company will be presenting at the
2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. ET in New
York, NY.
David R. Parkinson, President and
Chief Executive Officer, Peter
Virsik, Chief Operating Officer and Executive Vice
President, and David S. Wood, Chief
Financial Officer, will participate in a fireside chat.
A live webcast of the fireside chat can be accessed in the
Investors/Events & Presentations section of ESSA's website at
www.essapharma.com. Following the event, the webcast will be
archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage
pharmaceutical company focused on developing novel and proprietary
therapies for the treatment of patients with prostate cancer. For
more information, please visit www.essaphrma.com, and follow
us on X and LinkedIn.
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating
Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2024-cantor-global-healthcare-conference-302244410.html
SOURCE ESSA Pharma Inc
